CAR-T Cell Therapy Effective in Refractory Double-Hit/Triple-Hit Lymphoma
New study offers new option for improving outcomes for patients with double-hit and triple-hit lymphoma.
Related Articles
Erectile Dysfunction: What Are the Options When PDE5 inhibitors Fail?
PDE5 inhibitors are the first-line medical treatment for ED, but up to 40% of patients do not have a satisfactory response to these agents.
Nuclear CD55 Fuels Chemo Resistance in Ovarian Cancer
Cleveland Clinic researchers have discovered that the presence of the protein CD55 in cell nuclei can make ovarian cancer resistant to chemotherapy.
Teamwork and Quick Action Help 4-Year-Old with Mysterious Nasal Symptoms
When a pediatric patient presented with severe congestion, snoring and a progressive cough, X-ray findings revealed the surprising source of the patient’s symptoms.
Imaging Options Compared for Septal and Mitral Measurement in Myectomy for HOCM
New prospective data could shape how multimodality imaging is used in surgical planning for patients with hypertrophic obstructive cardiomyopathy. New research on optimal imaging modalities…
When Multiple Sclerosis Is Suspected in Patients Under 18 or Over 50
Expert group reviews the knowns and unknowns in differential diagnosis of pediatric-onset and late-onset multiple sclerosis.
Bicuspid Aortic Valve Disease: Multifaceted Challenges Demand Versatile Management
Less than 2% of the population has a bicuspid aortic valve (BAV), so experience treating BAV disease is limited. We share learnings from our large…
Aortic Valve Repair for Aortic Regurgitation: A Welcome Option in Experienced Hands
Here’s why we find aortic valve repair to be a durable and effective option for treating many patients with aortic regurgitation.
Losartan Eye Drops Now Used Off-Label to Eliminate Corneal Scarring
Studies continue to indicate effectiveness and safety of losartan eye drops to eliminate corneal scarring.
New Data Further Support Breast Cancer Polygenic Risk Score
Use of multiple-ancestry polygenic risk scores enhance prediction of breast cancer risk in Hispanic women.
De-intensifying Radiation Therapy in Low-Risk Breast Cancer
Unlike years ago when virtually all patients were prescribed a five-to-six-week course of radiation therapy, today selected patients with low-risk disease may have a shorter…